Company Update (NYSE:JNJ): Johnson & Johnson Partners with Leading Universities to Advance Women’s Education in Science, Technology, Engineering, Math, Manufacturing and Design (STEM2D)

[PR Newswire] – NEW BRUNSWICK, N.J., Jan. 6, 2016 /PRNewswire/ — Johnson & Johnson (JNJ) today announced it has entered into 10 partnerships around the world to help increase the number of undergraduate women enrolling in and declaring majors in the fields of Science, Technology, Engineering, Math, Manufacturing and Design (STEM2D). The partnerships are part of Johnson & Johnson’s commitment to harness the power of diversity to improve the health and well-being of people around the world. The partnerships include agreements with the National Center for Women and Information Technology (NCWIT) and nine leading academic centers around the world, including Caltech, Harvey Mudd College, Massachusetts Institute of Technology, Instituto Tecnológico de Aeronáutica (ITA – Brazil), Rhode Island School of Design, Rutgers-New Brunswick Honors College, Spelman College, The University of Tokyo, and The University of Limerick. Read more on this. Johnson & Johnson (JNJ) , valued at $277.77B, started the session at $99.75. Looking at the equity, the company’s one day range is $99.60 to $100.97 with the price of the stock fluctuating between $81.79 to $106.50 over the last 52 weeks. JNJ shares are currently priced at 16.26x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s -3.55x forward p/e ratio. And for dividend hunters, the company pays shareholders $3.00 per share annually in dividends, yielding 2.92%. According to a consensus of 19 analysts, the earnings estimate of $1.42 per share would be $0.05 better than the year-ago quarter and a $0.02 sequential decrease. Investors should also note that the full-year EPS estimate of $6.18 is a $0.21 worse when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $17.90 Billion. If reported, that would be a 1.92% decrease over the year-ago quarter. Recently, Barclays downgraded JNJ from Overweight to Equal Weight (Jan 10, 2014). Previously, RBC Capital Mkts upgraded JNJ from Sector Perform to Outperform. The average price target for JNJ shares by the analysts covering the stock is $108.00, which is 8.27% above where the stock opened this morning. See more in (NYSE:JNJ) Similar Articles: Stock Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to Participate in the 24th Annual Credit Suisse Health Care Conference Company Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2015 Market Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2015